Reports Q2 revenue $2.8M, consensus $1.47M. “Following the recent positive 36-month clinical data update with the OpRegen RPE cell therapy program, which is licensed by Genentech and Roche, we ...

Live Updates Live Coverage Updates appear automatically as they are published. How Rigetti Performed Last Quarter 3:00 pm Rigetti has missed EPS in 3 of the last 4 quarters. Market reaction has been ...

The Edmonton Police Service says it has seen an uptick in fatal collisions so far in 2025 compared to the same time last year ...

Oportun (OPRT) shows improved loan portfolio quality, profitability, and raised EPS guidance. Shares trade at a TBV discount.

Navigator Holdings (NVGS) came out with quarterly earnings of $0.14 per share, missing the Zacks Consensus Estimate of $0.36 per share. This compares to earnings of $0.34 per share a year ago. These ...

Micron Technology (NASDAQ:MU) extended gains Tuesday after boosting its August-quarter outlook, fueled by surging demand and ...

Tecogen Inc. (NYSE American:TGEN), a leading manufacturer of clean energy products, reported revenues of $7.29 million and net loss of $1.47 million for the quarter ended June 30, 2025 compared to ...

Discover why we rate Adobe a Strong Buy with a $604.27 price target, driven by AI monetization, platform lock-in, and ...

Paysafe Limited (NYSE:PSFE) shares surged on Tuesday after the payments platform topped Wall Street’s second-quarter earnings ...

BigBear.ai shares plunge 31.2% as Q2 revenues drop 18% Y/Y and the 2025 sales outlook is cut on Army program weakness.

TELA Bio (TELA) delivered earnings and revenue surprises of -22.22% and -1.72%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Accusing the DMK government of increased ‘corruption, commission and collection,’ Palaniswami cited various incidents of ...